NNC0363-0845

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 1Healthy Volunteers

Phase 1

A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes

CompletedNCT04569994

Novo Nordisk A/SDiabetes Mellitus, Type 1, Healthy Volunteers

Start: 2020-09-30End: 2021-06-23Updated: 2023-06-27

A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works

CompletedNCT05134987

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2021-12-01End: 2022-05-06Updated: 2022-11-04